Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.

Germing U, Strupp C, Kuendgen A, Aivado M, Giagounidis A, Hildebrandt B, Aul C, Haas R, Gattermann N.

Br J Haematol. 2006 Jan;132(2):162-7. Erratum in: Br J Haematol. 2006 Jul;134(2):247.

PMID:
16398650
2.

Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.

Strupp C, Gattermann N, Giagounidis A, Aul C, Hildebrandt B, Haas R, Germing U.

Leuk Res. 2003 May;27(5):397-404.

PMID:
12620291
3.

Refractory anaemia with excess of blasts in transformation re-evaluated with the WHO criteria: identification of subgroups with different survival.

Breccia M, Latagliata R, Carmosino I, Gentilini F, D'Elia GM, Levi A, Natalino F, Frustaci A, De Cuia MR, Alimena G.

Acta Haematol. 2007;117(4):221-5. Epub 2007 Jan 26.

PMID:
17259693
4.

Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal.

Breccia M, Latagliata R, Cannella L, Carmosino I, De Cuia R, Frustaci A, Stefanizzi C, Santopietro M, Alimena G.

Leuk Res. 2009 Mar;33(3):391-4. doi: 10.1016/j.leukres.2008.06.033. Epub 2008 Aug 3.

PMID:
18676015
5.
6.

The prognostic significance of auer rods in myelodysplasia.

Seymour JF, Estey EH.

Br J Haematol. 1993 Sep;85(1):67-76.

PMID:
8251411
7.

Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.

Knipp S, Strupp C, Gattermann N, Hildebrandt B, Schapira M, Giagounidis A, Aul C, Haas R, Germing U.

Leuk Res. 2008 Jan;32(1):33-7. Epub 2007 Apr 6.

PMID:
17412418
8.

Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.

Gyger M, Infante-Rivard C, D'Angelo G, Forest L, Lussier P.

Am J Hematol. 1988 May;28(1):13-20.

PMID:
3369432
9.
10.

Re-evaluation of refractory anemia with excess blasts in transformation.

Ohyashiki K, Nishimaki J, Shoji N, Miyazawa K, Kimura Y, Ohyashiki JH.

Leuk Res. 2001 Nov;25(11):933-9.

PMID:
11597728
11.

Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.

Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R.

Haematologica. 2006 Dec;91(12):1596-604.

12.

Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution.

Nösslinger T, Reisner R, Koller E, Grüner H, Tüchler H, Nowotny H, Pittermann E, Pfeilstöcker M.

Blood. 2001 Nov 15;98(10):2935-41.

13.
14.

[Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].

Schmitt-Graeff A, Mattern D, Köhler H, Hezel J, Lübbert M.

Pathologe. 2000 Jan;21(1):1-15. Review. German.

PMID:
10663664
15.

Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.

Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K.

Leuk Res. 2004 Jun;28(6):587-94.

PMID:
15120935
17.

Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.

Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW.

Leukemia. 1996 Jan;10(1):20-6.

PMID:
8558932
18.

Refractory anemia with excess of blasts in transformation hematologic and clinical study of 52 patients.

Michels SD, Saumur J, Arthur DC, Robison LL, Brunning RD.

Cancer. 1989 Dec 1;64(11):2340-6.

19.

Refractory anemia with excess of blasts in transformation. Clinical, hematologic, and cytogenetic findings in nine patients.

Smadja N, Krulik M, de Gramont A, Gonzalez-Canali G, Audebert AA, Debray J.

Cancer Genet Cytogenet. 1989 Oct 1;42(1):55-65.

PMID:
2790747
20.

Chronic myelomonocytic leukemia with antecedent refractory anemia with excess blasts: further evidence for the arbitrary nature of current classification systems.

Breccia M, Cannella L, Frustaci A, Stefanizzi C, D'Elia GM, Alimena G.

Leuk Lymphoma. 2008 Jul;49(7):1292-6. doi: 10.1080/10428190802123499.

PMID:
18604717

Supplemental Content

Support Center